Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine in Postural Tachycardia Syndrome
NCT00409435Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Oct 2006
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in postural orthostatic tachycardia syndrome (POTS), sponsored by Mayo Clinic. Started Oct 2006; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT00409435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409435.